SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-276883
Filing Date
2022-11-03
Accepted
2022-11-03 16:09:55
Documents
89
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d403730d10q.htm   iXBRL 10-Q 3035013
2 EX-31.1 d403730dex311.htm EX-31.1 10336
3 EX-31.2 d403730dex312.htm EX-31.2 10321
4 EX-32 d403730dex32.htm EX-32 4314
  Complete submission text file 0001193125-22-276883.txt   13057395

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20220930.xsd EX-101.SCH 82196
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20220930_cal.xml EX-101.CAL 48031
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20220930_def.xml EX-101.DEF 521620
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20220930_lab.xml EX-101.LAB 552962
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20220930_pre.xml EX-101.PRE 558924
83 EXTRACTED XBRL INSTANCE DOCUMENT d403730d10q_htm.xml XML 2985399
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 221358056
SIC: 2834 Pharmaceutical Preparations